GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$84.78 USD
+0.41 (0.49%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $84.75 -0.03 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GEHC 84.78 +0.41(0.49%)
Will GEHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GEHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GEHC
GE HealthCare's (GEHC) Tie-Up to Boost Female Pelvic Healthcare
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
GEHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
GE HealthCare (GEHC) Q2 Earnings Beat Estimates, Net Margin Up
Here's What Key Metrics Tell Us About GE HealthCare (GEHC) Q2 Earnings
Other News for GEHC
Brink's announces Teteak as Brinks Business System leader
GE HealthCare management to present at September investor conferences
Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency and Accuracy to Help Optimize Patient Care
GE HealthCare to Embark on a Collaboration to Elevate Women?s Imaging
GE HealthCare collaborates with University of California's CTIPM